Relevance of the mouse skin initiation–promotion model for the classification of carcinogenic substances encountered at the workplace
Section snippets
Current situation and issue
The “classical” standardized (Schmidt and Hecker, 1989, Filler et al., 2007) two-stage carcinogenesis experiment (synonym: initiation–promotion model) in dorsal mouse skin provides valuable mechanistic information on chemically provoked skin cancer development. In this standardized procedure, a carcinogen such as 7,12-dimethylbenz[a]anthracene (DMBA) is applied for tumor initiation – as a single dose – followed by repeated treatment with a tumor promoter, such as the phorbol ester 12-O
Quantitative aspects of DMBA/TPA tumor promotion in the skin
The dose and time response of TPA promotion was investigated in numerous experimental studies. Lutz et al. (1996) analyzed papilloma development on the dorsal mouse skin at a constant DMBA dose and variable TPA doses. Very low doses of DMBA (2 nmol; twice weekly) were applied in combination with TPA. The authors observed saturation of the papilloma response in the high TPA dose range. A 50% papilloma response was reached after ∼7 weeks at 10 nmol/application and after ∼8 weeks at 3 nmol. A papilloma
Evaluation of other compounds with promoting effects on the dorsal mouse skin in the two-stage initiation–promotion model
A large number of substances have tumor-promoting activity in the two-stage initiation–promotion model in dorsal mouse skin. The chemical structure of various tumor promoters is very heterogeneous, as are the assumed primary mechanism of action and the potency of the different substances. Table 1 shows some of the known active compounds (DiGiovanni, 1992).
Skin irritation is a common characteristic of the listed substances (see below). At certain doses, strong tumor promoters, such as TPA,
Actinic keratoses in humans as compared with chemically induced papillomas in mice
Papillomatous changes of the skin formed by the epidermis are quite common in humans and are sometimes caused by viruses. There is no direct equivalence to papillomas in mice because no malignant courses are known either morphologically or clinically (DiGiovanni, 1992). However, several authors are of the opinion that low-frequency high-risk papillomas might be a small subgroup of papillomas that were induced chemically in animal studies (Hennings et al., 1983, Hennings et al., 1985, Glick et
Evaluation
The experimental results available from model phorbol ester-type promoters indicate considerable species differences and steep dose–response relationships that have almost threshold characteristics. Conversely, the underlying mechanisms of tumor development in the skin of animals and humans are more or less the same, and RAS-mutated stem cells that can be promoted are presumably also latent in human skin. However, humans are probably considerably less susceptible to tumor promoters due to the
Transparency Document
Acknowledgments
We thank Prof. Helmut Greim for very helpful discussions and Ms. Patricia Brozena and Ms. Bettina Teschner for help in preparation of the manuscript.
References (72)
- et al.
The malignant capacity of skin tumours induced by expression of a mutant H-ras transgene depends on the cell type targeted
Curr. Biol.
(1998) - et al.
The multi-step process of human skin carcinogenesis: a role for p53, cyclin D1, hTERT, p16, and TSP-1
Eur. J. Cell Biol.
(2007) Multistage carcinogenesis in mouse skin
Pharmacol. Ther.
(1992)- et al.
Comparison of the skin tumor-promoting potential of different organic peroxides in SENCAR mice
Toxicol. Appl. Pharmacol.
(1998) - et al.
Irritant contact dermatitis in humans from phorbol and related esters
Toxicon
(1981) Carcinogenesis studies with benzoyl peroxide (Panoxyl gel 5%)
J. Invest. Dermatol.
(1986)Multistep skin cancer in mice as a model to study the evolution of cancer cells
Semin. Cancer Biol.
(2005)- et al.
Benzoyl peroxide: an integrated human safety assessment for carcinogenicity
Regul. Toxicol. Pharmacol.
(1995) - et al.
Studies on the promoting and complete carcinogenic activities of some oxidizing chemicals in skin carcinogenesis
Cancer Lett.
(1984) - et al.
Dose-time response in mouse skin tumor induction by 7, 12-dimethylbenz[a]anthracene and 12-O-tetradecanoyl-phorbol-13-acetate
Regul. Toxicol. Pharmacol.
(1996)